Sonova Holding (OTCMKTS:SONVY) Short Interest Update

Sonova Holding (OTCMKTS:SONVY) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totaling 2,188 shares, a decline of 17.7% from the November 30th total of 2,659 shares. Based on an average trading volume of 461,157 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 461,157 shares, the days-to-cover ratio is presently 0.0 days.

Sonova Stock Down 0.7%

Shares of SONVY stock opened at $51.83 on Friday. The business has a 50 day moving average of $51.69 and a two-hundred day moving average of $55.49. Sonova has a 52 week low of $47.55 and a 52 week high of $71.50. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 1.24.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SONVY. Zacks Research lowered shares of Sonova from a “hold” rating to a “strong sell” rating in a research note on Tuesday, December 9th. Rothschild Redb raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Royal Bank Of Canada raised shares of Sonova to a “moderate buy” rating in a research report on Tuesday, November 18th. Finally, BNP Paribas assumed coverage on Sonova in a research note on Monday, October 20th. They issued an “underperform” rating for the company. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.